Compare Rush Street Interactive Inc (RSI) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rush Street Interactive Inc vs 10X Genomics Inc — how do they compare? Rush Street Interactive Inc trades at $19.56 (market cap $2.35B), while 10X Genomics Inc trades at $81.44 (market cap $10.07B). The key difference: 10X Genomics Inc is far larger — about 4.3× Rush Street Interactive Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Rush Street Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Rush Street Interactive Inc for 13 Days and 10X Genomics Inc for 92 Days on average.
| RSI | TXG | |
|---|---|---|
Market Cap | $2.35B | $10.07B |
Volume | 2,219,374 | 5,657,286 |
Sector | Consumer Cyclical | Health |
52-Week High | $34.52 | $97.74 |
52-Week Low | $15.89 | $11.48 |
Typical Hold Time | 13 Days | 92 Days |
Enterprise Value | $2.01B | $9.59B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RSI trades at $19.89, down 1.73% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.15, beating estimates, and revenue growth to $1.4 billion projected for 2026. Analyst consensus is strongly bullish with a $34.88 price target, though net income margins remain thin at 2.33%.
The stock presents a mixed outlook: strong analyst support and revenue growth contrast with high valuation multiples and bearish technical trends. Key risks include competitive pressures in online gaming and reliance on sports betting cycles. Upside depends on margin improvement and execution of growth initiatives.
TXG trades at $76.10, down 5.65% on the day, reflecting a bearish technical trend. The company reported revenue of $642.82M for 2025 with a net loss of $43.54M, though it has consistently beaten quarterly EPS estimates. Recent news highlights strong demand for its Atera spatial biology platform and a patent victory. The stock faces resistance near $77 and support at $72.
The outlook is mixed; strong product demand and improving margins offer upside, but persistent losses and high valuation ratios pose risks. Analyst consensus is divided, with a $74.30 price target slightly below the current price, indicating cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
